P39429 (TRAF2_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 138.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: TNF receptor-associated factor 2 EC=6.3.2.- Alternative name(s): E3 ubiquitin-protein ligase TRAF2 | ||
| Gene names |
| ||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||
| Taxonomic identifier | 10090 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 501 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Regulates activation of NF-kappa-B and JNK and plays a central role in the regulation of cell survival and apoptosis. Required for normal antibody isotype switching from IgM to IgG. Has E3 ubiquitin-protein ligase activity and promotes 'Lys-63'-linked ubiquitination of target proteins, such as BIRC3, RIPK1 and TICAM1. Is an essential constituent of several E3 ubiquitin-protein ligase complexes, where it promotes the ubiquitination of target proteins by bringing them into contact with other E3 ubiquitin ligases. Regulates BIRC2 and BIRC3 protein levels by inhibiting their autoubiquitination and subsequent degradation; this does not depend on the TRAF2 RING-type zinc finger domain. Isoform 2 does not seem to mediate activation of NF-kappa-B but inhibits isoform 1 activity. Ref.9 Ref.12 Ref.17 Ref.20 Ref.21 Ref.23 Ref.24 |
| Enzyme regulation | Has very low E3 ubiquitin ligase activity in the absence of sphingosine-1-phosphate. E3 ubiquitin ligase activity is strongly activated by cytoplasmic sphingosine-1-phosphate By similarity. |
| Pathway | |
| Subunit structure | Homotrimer, and heterotrimer with TRAF1 and TRAF3 (via TRAF domain). The domain containing the RING-type and the first TRAF-type zinc finger can also form homodimers (in vitro). Interacts with TNFRSF1B/TNFR2, TNFRSF4, TNFRSF5/CD40, CD27/TNFRSF7, TNFRSF8/CD30, TNFRSF9/CD137, TNFRSF11A/RANK, TNFRSF13B/TACI, TNFRSF14, TNFRSF16/NGFR, TNFRSF17/BCMA, TNFRSF18/AITR, TNFRSF19/TROY, TNFRSF19L/RELT, XEDAR, EDAR, Epstein-Barr virus BNFL1/LMP-1 and IL15RA. Interacts with CDK9, CSK, MAP3K1, MAP3K5, MAP3K11, MAP3K14, MAP4K2, RIPK1, RIPK2, TNIK, TBK1, SPHK1, TRADD, TRAFD1, TRAIP, TANK/ITRAF, TNFAIP3, TDP2, MAVS/IPS1, TICAM1 and TRPC4AP. Interacts with CASP8AP2, NFATC2IP, PEG3 and HIVEP3. Interacts with BIRC2 and BIRC3 N-terminus; a single BIRC2 or BIRC3 molecule interacts with a heterotrimer formed by TRAF1 and TRAF2, or a TRAF2 homotrimer. Identified in a complex composed of TRAF2, TRAF3, BIRC2 and/or BIRC3. Interaction with BIRC2 and/or BIRC3 is essential for degradation of NFKBIA and activation of NF-kappa-B. Interacts with CYLD, USP48, DAB2IP, IKKA and IKKB. Interacts (via 'Lys-63'-linked polyubiquitin chains) with TAB2 and TAB3 By similarity. Interaction with TAOK3 is facilitated under ER stress conditions, such as treatment with tunicamycin, and may promote TRAF2 phosphorylation By similarity. Interacts with CASP12 under resting conditions; this interaction is reduced in ER stress conditions By similarity. Ref.1 Ref.7 Ref.8 Ref.10 Ref.11 Ref.13 Ref.14 Ref.15 Ref.16 Ref.18 Ref.19 Ref.20 Ref.21 Ref.22 Ref.23 |
| Subcellular location | |
| Tissue specificity | Isoform 1 and isoform 2 are expressed in spleen, adipose tissues, skeletal muscles, thymus, testis, heart, lung, brain. Isoform 2 is very weakly expressed in heart, lung and brain. |
| Domain | The coiled coil domain mediates homo- and hetero-oligomerization. Ref.23 The MATH/TRAF domain binds to receptor cytoplasmic domains. Ref.23 The RING-type zinc finger domain is essential for E3 ubiquitin-protein ligase activity. It is not essential for the stabilization of BIRC2, or for the ubiquitination of RIPK1 in response to TNFR1 signaling By similarity. Ref.23 |
| Post-translational modification | Phosphorylated at several serine residues within the first 128 amino acid residues. Phosphorylated at Thr-117 in response to signaling via TNF and TNFRSF1A. Phosphorylation at Thr-117 is required for 'Lys-63'-linked polyubiquitination, but not for 'Lys-48'-linked polyubiquitination. Phosphorylation at Thr-117 is important for interaction with IKKA and IKKB, activation of IKK and subsequent activation of NF-kappa-B By similarity. Undergoes both 'Lys-48'-linked and 'Lys-63'-linked polyubiquitination. Polyubiquitinated via 'Lys-63'-linked ubiquitin in response to TNF signaling; this requires prior phosphorylation at Thr-117. 'Lys-63'-linked polyubiquitination promotes TRAF2-mediated activation of NF-kappa-B. Can be polyubiquitinated at several Lys residues via 'Lys-48'-linked ubiquitin chains in response to TNF signaling, leading to proteasomal degradation. Autoubiquitinated, leading to its subsequent proteasomal degradation. Polyubiquitinated by BIRC2 and SIAH2, leading to its subsequent proteasomal degradation. Not ubiquitinated by BIRC3 or SIAH1. Deubiquitinated by CYLD, a protease that specifically cleaves 'Lys-63'-linked polyubiquitin chains By similarity. |
| Disruption phenotype | Important embryonic and perinatal mortality. Life-born mutants appear normal at birth, but are smaller than their littermates after three days, fail to thrive, and few survive more than three weeks. Thymus and spleen are severely atrophic, and mice display lymphopenia of both T and B lymphocytes, with normal erythrocyte counts. Their thymocytes are abnormally sensitive to TNF-induced cell death and exhibit high levels of spontaneous apoptosis. Macrophages are highly sensitive to TNF and produce high levels of nitric oxide (NO) in response to TNF. Likewise, endogenous TNF production is abnormally increased upon exposure to TNF. Symptoms are much attenuated in mice that are deficient for both Traf2 and Tnfrsf1a/Tnfr1, or Traf2 and Tnf. Likewise, deletion of one Map3k14 allele alleviates symptoms and rescues splenic atrophy and reduction of splenocyte numbers. Mice show normal IgM production in response to viral infection, but lack CD40-mediated proliferation of B-cells. They are deficient in antibody isotype switching and fail to produce IgG. Ref.9 Ref.12 Ref.20 Ref.24 |
| Sequence similarities | Belongs to the TNF receptor-associated factor family. A subfamily. Contains 1 MATH domain. Contains 1 RING-type zinc finger. Contains 2 TRAF-type zinc fingers. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| Birc3 | O08863 | 7 | EBI-520016,EBI-642236 | |
| Fcrla | Q920A9 | 5 | EBI-520016,EBI-646587 | |
| Mknk2 | Q8CDB0 | 3 | EBI-520016,EBI-646209 | |
| Tank | P70347-1 | 7 | EBI-520016,EBI-646125 | |
| Tnfaip3 | Q60769 | 3 | EBI-520016,EBI-646595 | |
| Tnfrsf4 | P47741 | 3 | EBI-520016,EBI-520001 | |
| Traf3 | Q60803 | 2 | EBI-520016,EBI-520135 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P39429-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P39429-2) Also known as: TRAF2A; The sequence of this isoform differs from the canonical sequence as follows: 62-62: L → LRCASILS | ||||||
| Note: No experimental confirmation available. On mRNA level, has a significantly shorter half-life than isoform 1. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed By similarity | ||||||
| Chain | 2 – 501 | 500 | TNF receptor-associated factor 2 | PRO_0000056400 | |||||
Regions | |||||||||
| Domain | 351 – 496 | 146 | MATH | ||||||
| Zinc finger | 34 – 73 | 40 | RING-type | ||||||
| Zinc finger | 124 – 180 | 57 | TRAF-type 1 | ||||||
| Zinc finger | 177 – 233 | 57 | TRAF-type 2 | ||||||
| Region | 283 – 293 | 11 | Important for interaction with BIRC2 and BIRC3 | ||||||
| Coiled coil | 298 – 348 | 51 | By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 2 | 1 | N-acetylalanine By similarity | ||||||
| Modified residue | 7 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 11 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 22 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 117 | 1 | Phosphothreonine; by PKC By similarity | ||||||
| Cross-link | 31 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) By similarity | |||||||
Natural variations | |||||||||
| Alternative sequence | 62 | 1 | L → LRCASILS in isoform 2. | VSP_007402 | |||||
Experimental info | |||||||||
| Mutagenesis | 34 | 1 | C → S: Loss of autoubiquitination. Ref.15 | ||||||
| Mutagenesis | 283 | 1 | E → A: Reduces interaction with BIRC2. Ref.23 | ||||||
| Mutagenesis | 292 | 1 | E → A: Almost abolishes interaction with BIRC2; when associated with A-294. Ref.23 | ||||||
| Mutagenesis | 294 | 1 | E → A: Almost abolishes interaction with BIRC2; when associated with A-292. Ref.23 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor." Rothe M., Wong S.C., Henzel W.J., Goeddel D.V. Cell 78:681-692(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH TRAF1 AND TNFRSF1B. |
| [2] | "Tumor necrosis factor receptor (TNFR)-associated factor 2A (TRAF2A), a TRAF2 splice variant with an extended RING finger domain that inhibits TNFR2-mediated NF-kappaB activation." Brink R., Lodish H.F. J. Biol. Chem. 273:4129-4134(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). Strain: C57BL/6. Tissue: Kidney. |
| [3] | "Complete structural characterisation of the mammalian and Drosophila TRAF genes: implications for TRAF evolution and the role of RING finger splice variants." Grech A., Quinn R., Srinivasan D., Badoux X., Brink R. Mol. Immunol. 37:721-734(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE (ISOFORM 1). Strain: C57BL/6. |
| [4] | "Lineage-specific biology revealed by a finished genome assembly of the mouse." Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S. Ponting C.P.PLoS Biol. 7:E1000112-E1000112(2009) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. Strain: C57BL/6J. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Strain: Czech II. Tissue: Mammary tumor. |
| [6] | Lubec G., Sunyer B., Chen W.-Q. Submitted (JAN-2009) to UniProtKB Cited for: PROTEIN SEQUENCE OF 430-440, MASS SPECTROMETRY. Strain: OF1. Tissue: Hippocampus. |
| [7] | "TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways." Hsu H., Shu H.-B., Pan M.G., Goeddel D.V. Cell 84:299-308(1996) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TRADD. |
| [8] | "The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation." Song H.Y., Rothe M., Goeddel D.V. Proc. Natl. Acad. Sci. U.S.A. 93:6721-6725(1996) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TNFAIP3. |
| [9] | "Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice." Yeh W.C., Shahinian A., Speiser D., Kraunus J., Billia F., Wakeham A., de la Pompa J.L., Ferrick D., Hum B., Iscove N., Ohashi P., Rothe M., Goeddel D.V., Mak T.W. Immunity 7:715-725(1997) [PubMed] [Europe PMC] [Abstract] Cited for: DISRUPTION PHENOTYPE, FUNCTION. |
| [10] | "Peg3/Pw1 is an imprinted gene involved in the TNF-NFkappaB signal transduction pathway." Relaix F., Wei X.-J., Wu X., Sassoon D.A. Nat. Genet. 18:287-291(1998) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PEG3. |
| [11] | "TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation." Lee S.Y., Lee S.Y., Choi Y. J. Exp. Med. 185:1275-1285(1997) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TRAIP. |
| [12] | "TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses." Nguyen L.T., Duncan G.S., Mirtsos C., Ng M., Speiser D.E., Shahinian A., Marino M.W., Mak T.W., Ohashi P.S., Yeh W.C. Immunity 11:379-389(1999) [PubMed] [Europe PMC] [Abstract] Cited for: DISRUPTION PHENOTYPE, FUNCTION. |
| [13] | "FLASH coordinates NF-kappa B activity via TRAF2." Choi Y.-H., Kim K.-B., Kim H.-H., Hong G.-S., Kwon Y.-K., Chung C.-W., Park Y.-M., Shen Z.-J., Kim B.J., Lee S.-Y., Jung Y.-K. J. Biol. Chem. 276:25073-25077(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH CASP8AP2. |
| [14] | "Tumor necrosis factor receptor-associated factor (TRAF)2 represses the T helper cell type 2 response through interaction with NFAT-interacting protein (NIP45)." Lieberson R., Mowen K.A., McBride K.D., Leautaud V., Zhang X., Suh W.-K., Wu L., Glimcher L.H. J. Exp. Med. 194:89-98(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH NFATC2IP. |
| [15] | "Regulation of TRAF2 signaling by self-induced degradation." Brown K.D., Hostager B.S., Bishop G.A. J. Biol. Chem. 277:19433-19438(2002) [PubMed] [Europe PMC] [Abstract] Cited for: AUTOUBIQUITINATION, DEGRADATION, INTERACTION WITH CD40, MUTAGENESIS OF CYS-34. |
| [16] | "A mammalian homolog of Drosophila schnurri, KRC, regulates TNF receptor-driven responses and interacts with TRAF2." Oukka M., Kim S.T., Lugo G., Sun J., Wu L.-C., Glimcher L.H. Mol. Cell 9:121-131(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH HIVEP3. |
| [17] | "The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2." Lee T.H., Shank J., Cusson N., Kelliher M.A. J. Biol. Chem. 279:33185-33191(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [18] | "TRUSS, a tumor necrosis factor receptor-1-interacting protein, activates c-Jun NH(2)-terminal kinase and transcription factor AP-1." Soond S.M., Terry J.L., Riches D.W.H. FEBS Lett. 580:4591-4596(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TRPC4AP. |
| [19] | "FLN29 deficiency reveals its negative regulatory role in the Toll-like receptor (TLR) and retinoic acid-inducible gene I (RIG-I)-like helicase signaling pathway." Sanada T., Takaesu G., Mashima R., Yoshida R., Kobayashi T., Yoshimura A. J. Biol. Chem. 283:33858-33864(2008) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TRAFD1. |
| [20] | "Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling." Vallabhapurapu S., Matsuzawa A., Zhang W., Tseng P.H., Keats J.J., Wang H., Vignali D.A., Bergsagel P.L., Karin M. Nat. Immunol. 9:1364-1370(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, DISRUPTION PHENOTYPE, IDENTIFICATION IN A COMPLEX WITH MAP3K14; BIRC3 AND TRAF3. |
| [21] | "Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK." Zarnegar B.J., Wang Y., Mahoney D.J., Dempsey P.W., Cheung H.H., He J., Shiba T., Yang X., Yeh W.C., Mak T.W., Korneluk R.G., Cheng G. Nat. Immunol. 9:1371-1378(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, IDENTIFICATION IN A COMPLEX WITH TRAF3; BIRC2 AND BIRC3. |
| [22] | "Enhanced cytoprotective effects of the inhibitor of apoptosis protein cellular IAP1 through stabilization with TRAF2." Csomos R.A., Brady G.F., Duckett C.S. J. Biol. Chem. 284:20531-20539(2009) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH BIRC2. |
| [23] | "TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (TNF) to efficiently activate NF-{kappa}B and to prevent TNF-induced apoptosis." Vince J.E., Pantaki D., Feltham R., Mace P.D., Cordier S.M., Schmukle A.C., Davidson A.J., Callus B.A., Wong W.W., Gentle I.E., Carter H., Lee E.F., Walczak H., Day C.L., Vaux D.L., Silke J. J. Biol. Chem. 284:35906-35915(2009) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH BIRC2; TRADD AND RIPK1, DOMAIN, MUTAGENESIS OF GLU-283; GLU-292 AND GLU-294. |
| [24] | "TRAF2 suppresses basal IKK activity in resting cells and TNFalpha can activate IKK in TRAF2 and TRAF5 double knockout cells." Zhang L., Blackwell K., Thomas G.S., Sun S., Yeh W.C., Habelhah H. J. Mol. Biol. 389:495-510(2009) [PubMed] [Europe PMC] [Abstract] Cited for: DISRUPTION PHENOTYPE, FUNCTION. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | L35303 mRNA. Translation: AAC37662.1. AF027570 mRNA. Translation: AAC53545.1. AF233332 AF233331 Genomic DNA. Translation: AAF59928.1.AL732590 Genomic DNA. Translation: CAM25164.1. BC003801 mRNA. Translation: AAH03801.1. |
| IPI | IPI00135901. IPI00271450. |
| PIR | I61512. |
| RefSeq | NP_033448.2. NM_009422.2. |
| UniGene | Mm.3399. |
3D structure databases | |
| ProteinModelPortal | P39429. |
| SMR | P39429. Positions 15-183, 267-501. |
| ModBase | Search... |
Protein-protein interaction databases | |
| DIP | DIP-468N. |
| IntAct | P39429. 42 interactions. |
| MINT | MINT-197749. |
PTM databases | |
| PhosphoSite | P39429. |
Proteomic databases | |
| PaxDb | P39429. |
| PRIDE | P39429. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENSMUST00000028311; ENSMUSP00000028311; ENSMUSG00000026942. ENSMUST00000114234; ENSMUSP00000109872; ENSMUSG00000026942. |
| GeneID | 22030. |
| KEGG | mmu:22030. |
| UCSC | uc008isl.1. mouse. |
Organism-specific databases | |
| CTD | 7186. |
| MGI | MGI:101835. Traf2. |
Phylogenomic databases | |
| eggNOG | NOG264247. |
| GeneTree | ENSGT00550000074359. |
| HOGENOM | HOG000231558. |
| HOVERGEN | HBG058222. |
| InParanoid | A2AJA3. |
| KO | K03173. |
| OMA | PSDGCTW. |
| OrthoDB | EOG4R502J. |
Enzyme and pathway databases | |
| UniPathway | UPA00143. |
Gene expression databases | |
| ArrayExpress | P39429. |
| Bgee | P39429. |
| CleanEx | MM_TRAF2. |
| Genevestigator | P39429. |
| GermOnline | ENSMUSG00000026942. Mus musculus. |
Family and domain databases | |
| Gene3D | 3.30.40.10. 1 hit. |
| InterPro | IPR002083. MATH. IPR012227. TNF_rcpt--assoc_TRAF. IPR008974. TRAF-like. IPR027133. TRAF2. IPR018957. Znf_C3HC4_RING-type. IPR001841. Znf_RING. IPR013083. Znf_RING/FYVE/PHD. IPR017907. Znf_RING_CS. IPR001293. Znf_TRAF. [Graphical view] |
| PANTHER | PTHR10131:SF21. PTHR10131:SF21. 1 hit. |
| Pfam | PF00917. MATH. 1 hit. PF00097. zf-C3HC4. 1 hit. [Graphical view] |
| PIRSF | PIRSF015614. TRAF. 1 hit. |
| SMART | SM00061. MATH. 1 hit. SM00184. RING. 1 hit. [Graphical view] |
| SUPFAM | SSF49599. Traf_like. 2 hits. |
| PROSITE | PS50144. MATH. 1 hit. PS00518. ZF_RING_1. 1 hit. PS50089. ZF_RING_2. 1 hit. PS50145. ZF_TRAF. 2 hits. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 301780. |
| SOURCE | Search... |
Entry information
| Entry name | TRAF2_MOUSE | ||||||||
| Accession | Primary (citable) accession number: P39429 Secondary accession number(s): A2AJA3, O54896 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| SIMILARITY comments Index of protein domains and families |

Clusters with
